Business

All four one, one four all?

With Scotland and England’s community pharmacy contracts up for renegotiation, Wales having secured a new deal and Northern Ireland hinting at a new approach, health economist Leela Barham takes stock and asks: who, when, what, why, and so what?

05 May 2022 , 4 Min Article

Digital & technology

Hub and spoke 2.0

As the Government opens another consultation on hub and spoke dispensing, are the benefits any clearer, and the pitfalls any closer to being resolved?

05 May 2022 , 1 Min Article

Legal

Working past 65: do's and don'ts

Those who use data and evidence to inform decisions stand a much better chance of staying out of an employment tribunal

04 May 2022 , 1 Min Article

Efficiency

Payment mistakes: a guide

As cash continues to decline inn use, the banking industry and Government are under pressure to provide better safeguards to protect customers

04 May 2022 , 1 Min Article

Legal

Soaring energy bills: whose tab?

With energy and utility costs rising fast, who pays in a business occupying rented premises? And what can be done to mitigate further increases?

04 May 2022 , 1 Min Article

Diabetes

An expanding role in diabetes care

Community pharmacy has a strong case to play a wider role in the prevention of type 2 diabetes and the care of patients who have the disease

04 May 2022 , 1 Min Article

Efficiency

A PMR check in

Annual update: PMR suppliers continue to step up their offerings to meet the evolving demands on their systems

04 May 2022 , 1 Min Article

Contract

For healthier incentives, go north

Scotland’s three-year funding deal for community pharmacy has a year to run. Leela Barham argues that, on paper at least, the deal has good incentives for helping to keep people healthy

03 May 2022 , 1 Min Article

Financial Management & Funding

The right incentives?

On paper at least, the new contractual framework in Wales has strong incentives to get value from community pharmacy that will benefit patients and the wider NHS